Status:
ACTIVE_NOT_RECRUITING
Adapting BA for Minimally Verbal Autistic Adults
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Autism
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study aims to adapt and evaluate the feasibility of the BeatIt-2 behavioral activation intervention for people with intellectual disabilities and low mood to be implemented with minimally ...
Detailed Description
Aim 1. The first phase of the project will focus on adapting the BeatIt-2 manual to consider specific needs of MV autistic adults. This procedure includes an intervention development group (IDG), for ...
Eligibility Criteria
Inclusion
- Minimally verbal
- Aged 18 years or older
- Diagnosis of Autism Spectrum Disorder and clinically significant depression based on clinical best estimate diagnosis using DSM-5 or Diagnostic Manual - Intellectual Disability criteria
- Have a support person willing to participate
- Live in New Jersey or New York, or be within travel distance to Rutgers University
Exclusion
- Not able to engage in treatment in English
- current engagement in other treatment for depression
- conditions that may preclude engagement in treatment sessions (e.g., active psychosis, unmanaged seizures)
- high suicide risk (i.e., with a clear plan, expressed intent or recent documented attempts)
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06064422
Start Date
November 1 2023
End Date
August 30 2025
Last Update
June 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers University - New Brunswick
Piscataway, New Jersey, United States, 08854